Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 386 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Androgen Receptor May Explain Sex Differences in Melanoma Treatment Response July 15, 2022 ESMO–ESTRO Joint Consensus Papers Address the Safety of Combining Radiotherapy with... May 5, 2026 Can Age Affect Response to Immune Checkpoint Inhibitors? July 6, 2018 Long-Term Outcomes in Patients with Metastatic Melanoma Treated with Anti-PD1 Therapy... October 28, 2021 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Lazertinib Less Frequent Mammographic Surveillance Non-inferior Compared with Annual Mammograms After Diagnosis... FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer SBRT Emerging as an Important Treatment for Early-Stage Kidney Cancer
